Stock Events

Stock Events

Search...

Fate Therapeutics (FATE) Q1 2023 Earnings

3MayConfirmed

Aug 22

Nov 22

Q4 2022

Q1 2023

-0.89

-0.66

-0.42

-0.19

Details

Expected EPS

-0.62

Actual EPS

-0.19

Surprise EPS

0.43

Surprise Percent

+69.35%

Description

Fate Therapeutics (FATE) has reported earnings of -0.19 per share for Q1 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.